Healthcare provider profile · identity verified

Chelsea A Springer, MD

Geriatric Medicine · LAKEWOOD, CO · NPI 1306226550

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	508	148
Atorvastatin Calcium	Atorvastatin Calcium	456	139
Amlodipine Besylate	Amlodipine Besylate	364	120
Losartan Potassium	Losartan Potassium	355	124
Gabapentin	Gabapentin	257	89
Lisinopril	Lisinopril	217	72
Rosuvastatin Calcium	Rosuvastatin Calcium	198	64
Omeprazole	Omeprazole	172	64
Duloxetine Hcl	Duloxetine Hcl	146	43
Pantoprazole Sodium	Pantoprazole Sodium	143	54
Trazodone Hcl	Trazodone Hcl	134	44
Hydrochlorothiazide	Hydrochlorothiazide	130	46
Simvastatin	Simvastatin	129	41
Furosemide	Furosemide	125	51
Alendronate Sodium	Alendronate Sodium	118	42
Famotidine	Famotidine	107	45
Eliquis	Apixaban	106	31
Tamsulosin Hcl	Tamsulosin Hcl	106	39
Escitalopram Oxalate	Escitalopram Oxalate	99	34
Sertraline Hcl	Sertraline Hcl	98	36
Metoprolol Succinate	Metoprolol Succinate	97	41
Tramadol Hcl	Tramadol Hcl	86	19
Venlafaxine Hcl Er	Venlafaxine Hcl	81	24
Metformin Hcl	Metformin Hcl	80	35
Albuterol Sulfate Hfa	Albuterol Sulfate	79	39
Citalopram Hbr	Citalopram Hydrobromide	76	20
Mirtazapine	Mirtazapine	74	27
Pravastatin Sodium	Pravastatin Sodium	72	27
Metoprolol Tartrate	Metoprolol Tartrate	67	26
Bupropion Xl	Bupropion Hcl	64	19
Buspirone Hcl	Buspirone Hcl	64	24
Allopurinol	Allopurinol	61	20
Synthroid	Levothyroxine Sodium	58	16
Fluoxetine Hcl	Fluoxetine Hcl	55	18
Potassium Chloride	Potassium Chloride	54	21
Atenolol	Atenolol	53	17
Finasteride	Finasteride	51	15
Clopidogrel	Clopidogrel Bisulfate	49	17
Esomeprazole Magnesium	Esomeprazole Magnesium	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	43	31
Spironolactone	Spironolactone	41	19
Carvedilol	Carvedilol	40	13
Prednisone	Prednisone	40	27
Estradiol	Estradiol	39	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	17
Oxycodone Hcl	Oxycodone Hcl	38	18
Alprazolam	Alprazolam	37	11
Ketoconazole	Ketoconazole	37	25
Azelastine Hcl	Azelastine Hcl	36	22
Meloxicam	Meloxicam	36	13
Ozempic	Semaglutide	35	11
Celecoxib	Celecoxib	34	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	17
Fluticasone Propionate	Fluticasone Propionate	33	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	12
Donepezil Hcl	Donepezil Hcl	31	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Metformin Hcl Er	Metformin Hcl	30	13
Pregabalin	Pregabalin	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	11
Glipizide Er	Glipizide	27	11
Valsartan	Valsartan	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Jardiance	Empagliflozin	25	11
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	11
Diclofenac Sodium	Diclofenac Sodium	21	11
Glipizide	Glipizide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	14
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Diazepam	Diazepam	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Memantine Hcl	Memantine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Torsemide	Torsemide	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Baclofen	Baclofen	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Wellbutrin Xl	Bupropion Hcl	14	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error